Published in Zh Mikrobiol Epidemiol Immunobiol on November 19, 2004
Treatment of Helicobacter pylori positive duodenal ulcers. Lancet (1990) 0.80
[Influence of probiotic enterococci on the growth of Streptococcus agalactiae]. Zh Mikrobiol Epidemiol Immunobiol (2007) 0.78
[Gastroesophageal reflux disease and respiratory apparatus pathology: the evidence of interrelation and unsolved problems]. Vestn Ross Akad Med Nauk (2005) 0.78
[Antisecretory therapy for prevention of stenoses of bougienage after-burn of esophageal strictures]. Eksp Klin Gastroenterol (2003) 0.77
Gastric cancer screening in selected population of Moscow region: retrospective evaluation. Eur Radiol (1999) 0.77
[Helicobacter pylori, endocrine cells of the gastric mucosa, and their function in duodenal ulcer]. Arkh Patol (1996) 0.77
[Influence of tableted green tea on index the antioxidant status patients with disease digestion organs]. Vopr Pitan (2008) 0.76
[Efficacy of using inulin fortified fermented milk products in patients with functional constipation]. Vopr Pitan (2009) 0.75
[The role of gastroesophageal reflux in malignization of post-burn and peptic esophageal strictures]. Vestn Ross Akad Med Nauk (2005) 0.75
[Use in immunohistochemical studies of a method of restoration of antigenic specificity as affected by microwaves in tissue fixed with formalin and embedded in paraffin]. Arkh Patol (1999) 0.75
[Optimal diagnosis and therapy of gastroesophageal reflux disease]. Ter Arkh (2004) 0.75
[Hepatic encephalopathy: its etiology, pathogenesis, clinical diagnostic criteria and treatment principles]. Ter Arkh (1990) 0.75
[Evaluation of contamination of the gastric mucosa with Helicobacter pylori and activity of chronic gastritis]. Arkh Patol (1995) 0.75
[The epidemiological aspects of infection caused by the lymphotropic herpesvirus 6]. Zh Mikrobiol Epidemiol Immunobiol (1997) 0.75
[Causes of postoperative recurrence and therapy of peptic ulcer]. Klin Med (Mosk) (1990) 0.75
[Project. Therapy of acid-dependent diseases. First Moscow Agreement, February 5, 2003]. Eksp Klin Gastroenterol (2003) 0.75
[Effectiveness of lamivudine in the treatment of chronic HBeAg-negative viral hepatitis B: results of continuous therapy for 18 months]. Klin Med (Mosk) (2003) 0.75
[Elastography for determination of hepatic fibrosis severity: registration study in Russia]. Eksp Klin Gastroenterol (2008) 0.75
[Comparative analysis of efficiency of the estimation of quality of life in patients with irritable bowel syndrome using questionnaires IBS-QOL and index BEST]. Eksp Klin Gastroenterol (2008) 0.75
[Impact of exogenic proteolytic enzymes on bacteria]. Antibiot Khimioter (2004) 0.75
[Chronic gastritis: current theories on its pathogenesis, clinical course and treatment]. Ter Arkh (1989) 0.75
[Characteristics of the endoscopic diagnosis of peptic ulcer and chronic gastritis associated with Campylobacter pylori]. Ter Arkh (1989) 0.75
[Diagnosis of measles in the outpatient polyclinic service]. Ter Arkh (1985) 0.75
[The rational use of De-Nol in the treatment of peptic ulcer and chronic active gastroduodenitis associated with Helicobacter pylori]. Ter Arkh (1992) 0.75
[Efficacy of fluoroquinolones on urological infection pathogens within biofilms]. Urologiia (2010) 0.75
[Concept of the mechanism of the therapeutic effect of flu chemotherapy]. Dokl Akad Nauk (1992) 0.75
[Isolation and properties of superoxide dismutase from human blood plasma]. Biokhimiia (1992) 0.75
[Photochemotherapy in the treatment of acute pneumonias]. Vestn Ross Akad Med Nauk (1994) 0.75
[Varying sensitivity to acyclovir of different years' clinical isolates of herpes simplex virus]. Vestn Ross Akad Med Nauk (1995) 0.75
[How can you assess the risk level in patients taking a NSAID and choose and algorithm of risk management? Gastroenterologist's expert opinion]. Eksp Klin Gastroenterol (2006) 0.75
[Experience with transendoscopic ultrasonic therapy of stomach ulcer]. Klin Med (Mosk) (1990) 0.75
[Long-term treatment of peptic ulcer with histamine H2 receptor blockaders: results of their use and new problems]. Klin Med (Mosk) (1991) 0.75
[Effect of exogenic proteolytic enzymes on transfer of plasmid genes in mixed bacterial biofilms]. Antibiot Khimioter (2009) 0.75
[Chronic HBeAg-negative viral gepatitis B: treatment is essential and possible]. Eksp Klin Gastroenterol (2007) 0.75
[Class I histocompatibility antigens as markers of human susceptibility to influenza A viruses]. Vestn Ross Akad Med Nauk (1995) 0.75
[Pharmacologic effect of anthropogenic air pollutants on children and prognosis for correction of these disorders]. Vestn Ross Akad Med Nauk (1994) 0.75
[Current possibilities of X-ray diagnosis of small intestine diseases using the agent Entero-view]. Vestn Rentgenol Radiol (2001) 0.75
[Use of sucralfate in the treatment of peptic ulcer]. Klin Med (Mosk) (1989) 0.75
[Modern strategy in the treatment of chronic hepatitis B: progress and prospects]. Eksp Klin Gastroenterol (2007) 0.75
[Characteristics of azithromycin action on bacterial biofilms of pneumonia pathogens]. Antibiot Khimioter (2007) 0.75
[New approaches to oral cavity opportunistic microbiota study]. Stomatologiia (Mosk) (2013) 0.75
[Changes in virulence of Enterobacteriaceae in the presence of sub-inhibitory levels of antibiotics]. Antibiot Khimioter (1991) 0.75
[Oral cavity microflora's role in human diseases development]. Stomatologiia (Mosk) (2008) 0.75
[Phases of peptic ulcer]. Klin Med (Mosk) (1989) 0.75
[Gastroesophageal reflux disease and Helicobacter pylori]. Klin Med (Mosk) (2000) 0.75
[Esomeprasol and rabeprasol effects on esophageal acidification in patients with gastroesophageal reflux disease, intensively metabolizing inhibitors of proton pump]. Ter Arkh (2005) 0.75
[The design and study of an ogt deletion mutant of Salmonella typhi]. Zh Mikrobiol Epidemiol Immunobiol (1998) 0.75
[Comparative analysis of the effectiveness of two Helicobacter pylori eradication plans based on omeprazole, clarithromycin and amoxicillin in patients with duodenal peptic ulcer: results of a randomized double-blind, controlled study]. Eksp Klin Gastroenterol (2003) 0.75
[Clinical characterization of patients with HIV infections]. Sov Med (1989) 0.75
[Famotidine--a new histamine H2 receptor blockader]. Klin Med (Mosk) (1991) 0.75
[Clinical and x-ray features of lung lesions in influenza uncomplicated and complicated by pneumonia]. Vestn Ross Akad Med Nauk (1995) 0.75
[Maastricht-3-2005: The Florentine mosaic of contradictions and compromises]. Eksp Klin Gastroenterol (2006) 0.75
[A complicated case of diagnosis of ileo-cecal tuberculosis]. Klin Med (Mosk) (2001) 0.75
[The role of temperature-dependent systems in regulating the properties of pathogenic bacteria]. Zh Mikrobiol Epidemiol Immunobiol (1994) 0.75
[Losek therapy of duodenal ulcer in contamination with different strains of Helicobacter pylori]. Klin Med (Mosk) (1999) 0.75
[Helicobacter pylori and its role in pathology]. Zh Mikrobiol Epidemiol Immunobiol (2003) 0.75
[Colloidal bismuth subcitrate (de-nol) in the treatment of peptic ulcer]. Klin Med (Mosk) (1989) 0.75
[Synthetic analog of prostaglandin E2 (enprostil) in the treatment of peptic ulcer]. Sov Med (1991) 0.75
[Local factors in the pathogenesis of peptic ulcer]. Klin Med (Mosk) (1988) 0.75
[Drug therapy and therapeutic tactics in gastroduodenal ulcer]. Ter Arkh (1988) 0.75
[Pharmacoeconomics in helicobacter pylori infection (lecture)]. Ter Arkh (2000) 0.75
[The comparative efficacy of ranitidine and famotidine in treating exacerbations of duodenal peptic ulcer]. Klin Med (Mosk) (1993) 0.75
[Unknown pathogens from the human oral microflora of interest for otorhinolaryngology]. Vestn Otorinolaringol (2014) 0.75
[Influence of cultivation conditions on bacterial DNA content and bacterial membrane permeability]. Vestn Ross Akad Med Nauk (2005) 0.75
[Current views on the etiology and pathogenesis of peptic ulcer]. Vestn Akad Med Nauk SSSR (1990) 0.75
[Campylobacter pyloridis in chronic gastritis and peptic ulcer]. Sov Med (1988) 0.75
[Current concepts of chronic gastritis (a review of the literature)]. Vrach Delo (1988) 0.75
[Selection of the surgery method for patients with high "stomach ulcers"]. Eksp Klin Gastroenterol (2005) 0.75
[Experience with the treatment of duodenal ulcer associated with Campylobacter pylori infection by combined use of anti-secretory and antibacterial drugs]. Klin Med (Mosk) (1989) 0.75
[Mortality and lethality of influenza and acute respiratory diseases]. Vestn Ross Akad Med Nauk (1994) 0.75
[Serological methods of diagnosis of Helicobacter pylori infections: recommendations and perspective of use]. Klin Lab Diagn (2000) 0.75
[Combined action of levofloxacin and DNAase on biofilms of urogenital infection pathogens]. Urologiia (2012) 0.75
[Chronic pancreatitis: current theories on its etiology, pathogenesis, clinical course and drug treatment (review of foreign literature)]. Klin Med (Mosk) (1988) 0.75
[Heartburn prevalence analysis: national epidemiologic examination of adult urban population (ARIADNE)]. Eksp Klin Gastroenterol (2008) 0.75
[Pathophysiologic bases of the pharmacotherapy of peptic ulcer]. Klin Med (Mosk) (1988) 0.75
[The diagnosis of stomach cancer: the status of the problem, the outlook for improvement and the clinico-morphological aspects]. Ter Arkh (1997) 0.75
[Use of cyclophosphane pulse-therapy in the treatment of severe nonspecific ulcerative colitis]. Klin Med (Mosk) (1994) 0.75
[Bronchial asthma and gastroesophageal reflux disease: are they interrelated by chance?]. Klin Med (Mosk) (2005) 0.75
[Enzyme DNA-ase use in patients with maxillofacial abscesses and phlegmons]. Stomatologiia (Mosk) (2006) 0.75
[Current approaches to the treatment of severe influenza]. Vestn Ross Akad Med Nauk (1994) 0.75
[New aspects in the etiology and pathogenesis of chronic gastritis and peptic ulcer]. Ter Arkh (1988) 0.75
[The pathogenetic bases of alimentary obesity]. Ter Arkh (1989) 0.75
[Liver damage caused by HIV infection]. Klin Med (Mosk) (1989) 0.75
[Results of an open multicenter study of the efficiency of one-week anti-helicobacter therapy using omeprazole, clarithromycin, and amoxicillin in patients with duodenal peptic ulcer]. Ter Arkh (2003) 0.75
[Proton pump inhibitors as the basis of anti-helicobacter therapeutic schemes]. Eksp Klin Gastroenterol (2004) 0.75
[The effectiveness of antibiotics on bacteria in biofilms]. Zh Mikrobiol Epidemiol Immunobiol (2005) 0.75
[Comparative effectiveness of the antisecretory action of rabeprazole and esomeprazole in people with rapid metabolism of proton pump inhibitors]. Eksp Klin Gastroenterol (2003) 0.75
[Functional activity of neutrophilic granulocytes in patients with relapsing herpes]. Biull Eksp Biol Med (1995) 0.75
[Epidemiologic aspects of human herpes virus infection type VI]. Vestn Ross Akad Med Nauk (1994) 0.75
[A method of determining Campylobacter pylori in the gastric mucosa in peptic ulcer and chronic gastritis]. Lab Delo (1989) 0.75
[GERD epidemiology: East and West]. Eksp Klin Gastroenterol (2004) 0.75
[A non-invasive method of evaluation of Helicobacter pylori urease activity: its perfection and introduction to clinical practice]. Vestn Ross Akad Med Nauk (2006) 0.75
[A case of death from AIDS in the USSR]. Ter Arkh (1989) 0.75
[Etiologic and pathologic approaches to pharmacotherapy of peptic ulcer]. Ter Arkh (1991) 0.75
[Activation of the alarm response of Escherichia by antibiotics]. Zh Mikrobiol Epidemiol Immunobiol (1990) 0.75
[Treatment of cholelithiasis]. Sov Med (1988) 0.75
[Pathogenesis of severe influenza]. Vestn Ross Akad Med Nauk (1994) 0.75
[Contacts between the cells in bacterial colonies]. Zh Mikrobiol Epidemiol Immunobiol (1991) 0.75